La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats

Identifieur interne : 001365 ( PascalFrancis/Corpus ); précédent : 001364; suivant : 001366

Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats

Auteurs : C. Perier ; M. Vila ; J. Feger ; Y. Agid ; E. C. Hirsch

Source :

RBID : Pascal:00-0327907

Descripteurs français

English descriptors

Abstract

The cellular expression of cytochrome oxidase subunit I (COI) mRNA as a metabolic marker for neuronal activity has recently been used to examine the effects of nigrostriatal denervation on the functioning of the basal ganglia. However, this technique also allows functional changes to be detected in other cerebral structures in parkinsonian syndromes. Since the zona incerta has been implicated in locomotor activity and has been the site of stereotactic surgery in Parkinson's disease, the aim of our study was to determine whether changes in neuronal activity are observed in this structure during parkinsonism. Using in situ hybridization, we analyzed the expression of COI mRNA in rats with 6-hydroxydopamine unilateral lesion of the substantia nigra and sham-operated animals. A quantitative analysis showed that COI mRNA expression was increased in the zona incerta ipsilateral to the lesion 24 h and 3 days after lesion, but by day 14 had returned almost to the level observed in controls. The hyperactivity of zona incerta neurons was confirmed by single-unit electrophysiological recordings. In contrast to the COI mRNA expression, the increase in electric neuronal activity was still observed 1 month after the lesion. This increase in zona incerta neuronal activity after nigrostriatal denervation might be related to the pathophysiology of parkinsonism, at least in the early stages, in agreement with previous reports suggesting an involvement of the zona incerta in motor functions.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0014-4886
A02 01      @0 EXNEAC
A03   1    @0 Exp. neurol. : (Print)
A05       @2 162
A06       @2 1
A08 01  1  ENG  @1 Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats
A11 01  1    @1 PERIER (C.)
A11 02  1    @1 VILA (M.)
A11 03  1    @1 FEGER (J.)
A11 04  1    @1 AGID (Y.)
A11 05  1    @1 HIRSCH (E. C.)
A14 01      @1 INSERM U 289, Hopital de la Salpêtrière, 47 Boulevard de l'Hôpital @2 75013 Paris @3 FRA @Z 1 aut. @Z 2 aut. @Z 4 aut. @Z 5 aut.
A14 02      @1 Faculté de Pharmacie, 4 avenue de l'observatorie @2 75006 Paris @3 FRA @Z 3 aut.
A20       @1 215-224
A21       @1 2000
A23 01      @0 ENG
A43 01      @1 INIST @2 9181 @5 354000082166090190
A44       @0 0000 @1 © 2000 INIST-CNRS. All rights reserved.
A45       @0 38 ref.
A47 01  1    @0 00-0327907
A60       @1 P
A61       @0 A
A64 01  1    @0 Experimental neurology : (Print)
A66 01      @0 USA
C01 01    ENG  @0 The cellular expression of cytochrome oxidase subunit I (COI) mRNA as a metabolic marker for neuronal activity has recently been used to examine the effects of nigrostriatal denervation on the functioning of the basal ganglia. However, this technique also allows functional changes to be detected in other cerebral structures in parkinsonian syndromes. Since the zona incerta has been implicated in locomotor activity and has been the site of stereotactic surgery in Parkinson's disease, the aim of our study was to determine whether changes in neuronal activity are observed in this structure during parkinsonism. Using in situ hybridization, we analyzed the expression of COI mRNA in rats with 6-hydroxydopamine unilateral lesion of the substantia nigra and sham-operated animals. A quantitative analysis showed that COI mRNA expression was increased in the zona incerta ipsilateral to the lesion 24 h and 3 days after lesion, but by day 14 had returned almost to the level observed in controls. The hyperactivity of zona incerta neurons was confirmed by single-unit electrophysiological recordings. In contrast to the COI mRNA expression, the increase in electric neuronal activity was still observed 1 month after the lesion. This increase in zona incerta neuronal activity after nigrostriatal denervation might be related to the pathophysiology of parkinsonism, at least in the early stages, in agreement with previous reports suggesting an involvement of the zona incerta in motor functions.
C02 01  X    @0 002B17G
C03 01  X  FRE  @0 Parkinson maladie @5 01
C03 01  X  ENG  @0 Parkinson disease @5 01
C03 01  X  SPA  @0 Parkinson enfermedad @5 01
C03 02  X  FRE  @0 Unilatéral @5 02
C03 02  X  ENG  @0 Unilateral @5 02
C03 02  X  SPA  @0 Unilateral @5 02
C03 03  X  FRE  @0 Capacité fonctionnelle @5 04
C03 03  X  ENG  @0 Functional capacity @5 04
C03 03  X  SPA  @0 Capacidad funcional @5 04
C03 04  X  FRE  @0 Neurone @5 05
C03 04  X  ENG  @0 Neuron @5 05
C03 04  X  SPA  @0 Neurona @5 05
C03 05  X  FRE  @0 Zona incerta @5 06
C03 05  X  ENG  @0 Zona incerta @5 06
C03 05  X  SPA  @0 Zona incierta @5 06
C03 06  X  FRE  @0 Enervation @5 07
C03 06  X  ENG  @0 Denervation @5 07
C03 06  X  SPA  @0 Denervación @5 07
C03 07  X  FRE  @0 Voie nigrostriatale @5 08
C03 07  X  ENG  @0 Nigrostriatal pathway @5 08
C03 07  X  SPA  @0 Vía nigroestriatal @5 08
C03 08  X  FRE  @0 Physiopathologie @5 17
C03 08  X  ENG  @0 Pathophysiology @5 17
C03 08  X  SPA  @0 Fisiopatología @5 17
C03 09  X  FRE  @0 Animal @5 20
C03 09  X  ENG  @0 Animal @5 20
C03 09  X  SPA  @0 Animal @5 20
C03 10  X  FRE  @0 Rat @5 21
C03 10  X  ENG  @0 Rat @5 21
C03 10  X  SPA  @0 Rata @5 21
C07 01  X  FRE  @0 Rodentia @2 NS
C07 01  X  ENG  @0 Rodentia @2 NS
C07 01  X  SPA  @0 Rodentia @2 NS
C07 02  X  FRE  @0 Mammalia @2 NS
C07 02  X  ENG  @0 Mammalia @2 NS
C07 02  X  SPA  @0 Mammalia @2 NS
C07 03  X  FRE  @0 Vertebrata @2 NS
C07 03  X  ENG  @0 Vertebrata @2 NS
C07 03  X  SPA  @0 Vertebrata @2 NS
C07 04  X  FRE  @0 Système nerveux pathologie @5 37
C07 04  X  ENG  @0 Nervous system diseases @5 37
C07 04  X  SPA  @0 Sistema nervioso patología @5 37
C07 05  X  FRE  @0 Système nerveux central pathologie @5 38
C07 05  X  ENG  @0 Central nervous system disease @5 38
C07 05  X  SPA  @0 Sistema nervosio central patología @5 38
C07 06  X  FRE  @0 Encéphale pathologie @5 39
C07 06  X  ENG  @0 Cerebral disorder @5 39
C07 06  X  SPA  @0 Encéfalo patología @5 39
C07 07  X  FRE  @0 Extrapyramidal syndrome @5 40
C07 07  X  ENG  @0 Extrapyramidal syndrome @5 40
C07 07  X  SPA  @0 Extrapiramidal síndrome @5 40
C07 08  X  FRE  @0 Maladie dégénérative @5 41
C07 08  X  ENG  @0 Degenerative disease @5 41
C07 08  X  SPA  @0 Enfermedad degenerativa @5 41
N21       @1 220

Format Inist (serveur)

NO : PASCAL 00-0327907 INIST
ET : Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats
AU : PERIER (C.); VILA (M.); FEGER (J.); AGID (Y.); HIRSCH (E. C.)
AF : INSERM U 289, Hopital de la Salpêtrière, 47 Boulevard de l'Hôpital/75013 Paris/France (1 aut., 2 aut., 4 aut., 5 aut.); Faculté de Pharmacie, 4 avenue de l'observatorie/75006 Paris/France (3 aut.)
DT : Publication en série; Niveau analytique
SO : Experimental neurology : (Print); ISSN 0014-4886; Coden EXNEAC; Etats-Unis; Da. 2000; Vol. 162; No. 1; Pp. 215-224; Bibl. 38 ref.
LA : Anglais
EA : The cellular expression of cytochrome oxidase subunit I (COI) mRNA as a metabolic marker for neuronal activity has recently been used to examine the effects of nigrostriatal denervation on the functioning of the basal ganglia. However, this technique also allows functional changes to be detected in other cerebral structures in parkinsonian syndromes. Since the zona incerta has been implicated in locomotor activity and has been the site of stereotactic surgery in Parkinson's disease, the aim of our study was to determine whether changes in neuronal activity are observed in this structure during parkinsonism. Using in situ hybridization, we analyzed the expression of COI mRNA in rats with 6-hydroxydopamine unilateral lesion of the substantia nigra and sham-operated animals. A quantitative analysis showed that COI mRNA expression was increased in the zona incerta ipsilateral to the lesion 24 h and 3 days after lesion, but by day 14 had returned almost to the level observed in controls. The hyperactivity of zona incerta neurons was confirmed by single-unit electrophysiological recordings. In contrast to the COI mRNA expression, the increase in electric neuronal activity was still observed 1 month after the lesion. This increase in zona incerta neuronal activity after nigrostriatal denervation might be related to the pathophysiology of parkinsonism, at least in the early stages, in agreement with previous reports suggesting an involvement of the zona incerta in motor functions.
CC : 002B17G
FD : Parkinson maladie; Unilatéral; Capacité fonctionnelle; Neurone; Zona incerta; Enervation; Voie nigrostriatale; Physiopathologie; Animal; Rat
FG : Rodentia; Mammalia; Vertebrata; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative
ED : Parkinson disease; Unilateral; Functional capacity; Neuron; Zona incerta; Denervation; Nigrostriatal pathway; Pathophysiology; Animal; Rat
EG : Rodentia; Mammalia; Vertebrata; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease
SD : Parkinson enfermedad; Unilateral; Capacidad funcional; Neurona; Zona incierta; Denervación; Vía nigroestriatal; Fisiopatología; Animal; Rata
LO : INIST-9181.354000082166090190
ID : 00-0327907

Links to Exploration step

Pascal:00-0327907

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats</title>
<author>
<name sortKey="Perier, C" sort="Perier, C" uniqKey="Perier C" first="C." last="Perier">C. Perier</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U 289, Hopital de la Salpêtrière, 47 Boulevard de l'Hôpital</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Vila, M" sort="Vila, M" uniqKey="Vila M" first="M." last="Vila">M. Vila</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U 289, Hopital de la Salpêtrière, 47 Boulevard de l'Hôpital</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Feger, J" sort="Feger, J" uniqKey="Feger J" first="J." last="Feger">J. Feger</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Faculté de Pharmacie, 4 avenue de l'observatorie</s1>
<s2>75006 Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Y. Agid</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U 289, Hopital de la Salpêtrière, 47 Boulevard de l'Hôpital</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Hirsch, E C" sort="Hirsch, E C" uniqKey="Hirsch E" first="E. C." last="Hirsch">E. C. Hirsch</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U 289, Hopital de la Salpêtrière, 47 Boulevard de l'Hôpital</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">00-0327907</idno>
<date when="2000">2000</date>
<idno type="stanalyst">PASCAL 00-0327907 INIST</idno>
<idno type="RBID">Pascal:00-0327907</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001365</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats</title>
<author>
<name sortKey="Perier, C" sort="Perier, C" uniqKey="Perier C" first="C." last="Perier">C. Perier</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U 289, Hopital de la Salpêtrière, 47 Boulevard de l'Hôpital</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Vila, M" sort="Vila, M" uniqKey="Vila M" first="M." last="Vila">M. Vila</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U 289, Hopital de la Salpêtrière, 47 Boulevard de l'Hôpital</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Feger, J" sort="Feger, J" uniqKey="Feger J" first="J." last="Feger">J. Feger</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Faculté de Pharmacie, 4 avenue de l'observatorie</s1>
<s2>75006 Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Agid, Y" sort="Agid, Y" uniqKey="Agid Y" first="Y." last="Agid">Y. Agid</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U 289, Hopital de la Salpêtrière, 47 Boulevard de l'Hôpital</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Hirsch, E C" sort="Hirsch, E C" uniqKey="Hirsch E" first="E. C." last="Hirsch">E. C. Hirsch</name>
<affiliation>
<inist:fA14 i1="01">
<s1>INSERM U 289, Hopital de la Salpêtrière, 47 Boulevard de l'Hôpital</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Experimental neurology : (Print)</title>
<title level="j" type="abbreviated">Exp. neurol. : (Print)</title>
<idno type="ISSN">0014-4886</idno>
<imprint>
<date when="2000">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Experimental neurology : (Print)</title>
<title level="j" type="abbreviated">Exp. neurol. : (Print)</title>
<idno type="ISSN">0014-4886</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animal</term>
<term>Denervation</term>
<term>Functional capacity</term>
<term>Neuron</term>
<term>Nigrostriatal pathway</term>
<term>Parkinson disease</term>
<term>Pathophysiology</term>
<term>Rat</term>
<term>Unilateral</term>
<term>Zona incerta</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Parkinson maladie</term>
<term>Unilatéral</term>
<term>Capacité fonctionnelle</term>
<term>Neurone</term>
<term>Zona incerta</term>
<term>Enervation</term>
<term>Voie nigrostriatale</term>
<term>Physiopathologie</term>
<term>Animal</term>
<term>Rat</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The cellular expression of cytochrome oxidase subunit I (COI) mRNA as a metabolic marker for neuronal activity has recently been used to examine the effects of nigrostriatal denervation on the functioning of the basal ganglia. However, this technique also allows functional changes to be detected in other cerebral structures in parkinsonian syndromes. Since the zona incerta has been implicated in locomotor activity and has been the site of stereotactic surgery in Parkinson's disease, the aim of our study was to determine whether changes in neuronal activity are observed in this structure during parkinsonism. Using in situ hybridization, we analyzed the expression of COI mRNA in rats with 6-hydroxydopamine unilateral lesion of the substantia nigra and sham-operated animals. A quantitative analysis showed that COI mRNA expression was increased in the zona incerta ipsilateral to the lesion 24 h and 3 days after lesion, but by day 14 had returned almost to the level observed in controls. The hyperactivity of zona incerta neurons was confirmed by single-unit electrophysiological recordings. In contrast to the COI mRNA expression, the increase in electric neuronal activity was still observed 1 month after the lesion. This increase in zona incerta neuronal activity after nigrostriatal denervation might be related to the pathophysiology of parkinsonism, at least in the early stages, in agreement with previous reports suggesting an involvement of the zona incerta in motor functions.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0014-4886</s0>
</fA01>
<fA02 i1="01">
<s0>EXNEAC</s0>
</fA02>
<fA03 i2="1">
<s0>Exp. neurol. : (Print)</s0>
</fA03>
<fA05>
<s2>162</s2>
</fA05>
<fA06>
<s2>1</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>PERIER (C.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>VILA (M.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>FEGER (J.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>AGID (Y.)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>HIRSCH (E. C.)</s1>
</fA11>
<fA14 i1="01">
<s1>INSERM U 289, Hopital de la Salpêtrière, 47 Boulevard de l'Hôpital</s1>
<s2>75013 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Faculté de Pharmacie, 4 avenue de l'observatorie</s1>
<s2>75006 Paris</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA20>
<s1>215-224</s1>
</fA20>
<fA21>
<s1>2000</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>9181</s2>
<s5>354000082166090190</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2000 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>38 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>00-0327907</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Experimental neurology : (Print)</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>The cellular expression of cytochrome oxidase subunit I (COI) mRNA as a metabolic marker for neuronal activity has recently been used to examine the effects of nigrostriatal denervation on the functioning of the basal ganglia. However, this technique also allows functional changes to be detected in other cerebral structures in parkinsonian syndromes. Since the zona incerta has been implicated in locomotor activity and has been the site of stereotactic surgery in Parkinson's disease, the aim of our study was to determine whether changes in neuronal activity are observed in this structure during parkinsonism. Using in situ hybridization, we analyzed the expression of COI mRNA in rats with 6-hydroxydopamine unilateral lesion of the substantia nigra and sham-operated animals. A quantitative analysis showed that COI mRNA expression was increased in the zona incerta ipsilateral to the lesion 24 h and 3 days after lesion, but by day 14 had returned almost to the level observed in controls. The hyperactivity of zona incerta neurons was confirmed by single-unit electrophysiological recordings. In contrast to the COI mRNA expression, the increase in electric neuronal activity was still observed 1 month after the lesion. This increase in zona incerta neuronal activity after nigrostriatal denervation might be related to the pathophysiology of parkinsonism, at least in the early stages, in agreement with previous reports suggesting an involvement of the zona incerta in motor functions.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Parkinson maladie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Parkinson disease</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Parkinson enfermedad</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Unilatéral</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Unilateral</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Unilateral</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Capacité fonctionnelle</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Functional capacity</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Capacidad funcional</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Neurone</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Neuron</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Neurona</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Zona incerta</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Zona incerta</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Zona incierta</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Enervation</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Denervation</s0>
<s5>07</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Denervación</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Voie nigrostriatale</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Nigrostriatal pathway</s0>
<s5>08</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Vía nigroestriatal</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Physiopathologie</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Pathophysiology</s0>
<s5>17</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Fisiopatología</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Animal</s0>
<s5>20</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Animal</s0>
<s5>20</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Animal</s0>
<s5>20</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Rat</s0>
<s5>21</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Rat</s0>
<s5>21</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Rata</s0>
<s5>21</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Système nerveux pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Nervous system diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Sistema nervioso patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Système nerveux central pathologie</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Central nervous system disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Sistema nervosio central patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Encéphale pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Cerebral disorder</s0>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Encéfalo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Extrapyramidal syndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Extrapiramidal síndrome</s0>
<s5>40</s5>
</fC07>
<fC07 i1="08" i2="X" l="FRE">
<s0>Maladie dégénérative</s0>
<s5>41</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG">
<s0>Degenerative disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA">
<s0>Enfermedad degenerativa</s0>
<s5>41</s5>
</fC07>
<fN21>
<s1>220</s1>
</fN21>
</pA>
</standard>
<server>
<NO>PASCAL 00-0327907 INIST</NO>
<ET>Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats</ET>
<AU>PERIER (C.); VILA (M.); FEGER (J.); AGID (Y.); HIRSCH (E. C.)</AU>
<AF>INSERM U 289, Hopital de la Salpêtrière, 47 Boulevard de l'Hôpital/75013 Paris/France (1 aut., 2 aut., 4 aut., 5 aut.); Faculté de Pharmacie, 4 avenue de l'observatorie/75006 Paris/France (3 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Experimental neurology : (Print); ISSN 0014-4886; Coden EXNEAC; Etats-Unis; Da. 2000; Vol. 162; No. 1; Pp. 215-224; Bibl. 38 ref.</SO>
<LA>Anglais</LA>
<EA>The cellular expression of cytochrome oxidase subunit I (COI) mRNA as a metabolic marker for neuronal activity has recently been used to examine the effects of nigrostriatal denervation on the functioning of the basal ganglia. However, this technique also allows functional changes to be detected in other cerebral structures in parkinsonian syndromes. Since the zona incerta has been implicated in locomotor activity and has been the site of stereotactic surgery in Parkinson's disease, the aim of our study was to determine whether changes in neuronal activity are observed in this structure during parkinsonism. Using in situ hybridization, we analyzed the expression of COI mRNA in rats with 6-hydroxydopamine unilateral lesion of the substantia nigra and sham-operated animals. A quantitative analysis showed that COI mRNA expression was increased in the zona incerta ipsilateral to the lesion 24 h and 3 days after lesion, but by day 14 had returned almost to the level observed in controls. The hyperactivity of zona incerta neurons was confirmed by single-unit electrophysiological recordings. In contrast to the COI mRNA expression, the increase in electric neuronal activity was still observed 1 month after the lesion. This increase in zona incerta neuronal activity after nigrostriatal denervation might be related to the pathophysiology of parkinsonism, at least in the early stages, in agreement with previous reports suggesting an involvement of the zona incerta in motor functions.</EA>
<CC>002B17G</CC>
<FD>Parkinson maladie; Unilatéral; Capacité fonctionnelle; Neurone; Zona incerta; Enervation; Voie nigrostriatale; Physiopathologie; Animal; Rat</FD>
<FG>Rodentia; Mammalia; Vertebrata; Système nerveux pathologie; Système nerveux central pathologie; Encéphale pathologie; Extrapyramidal syndrome; Maladie dégénérative</FG>
<ED>Parkinson disease; Unilateral; Functional capacity; Neuron; Zona incerta; Denervation; Nigrostriatal pathway; Pathophysiology; Animal; Rat</ED>
<EG>Rodentia; Mammalia; Vertebrata; Nervous system diseases; Central nervous system disease; Cerebral disorder; Extrapyramidal syndrome; Degenerative disease</EG>
<SD>Parkinson enfermedad; Unilateral; Capacidad funcional; Neurona; Zona incierta; Denervación; Vía nigroestriatal; Fisiopatología; Animal; Rata</SD>
<LO>INIST-9181.354000082166090190</LO>
<ID>00-0327907</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001365 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 001365 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:00-0327907
   |texte=   Functional activity of zona incerta neurons is altered after nigrostriatal denervation in hemiparkinsonian rats
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024